ARCHIVES

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

Scientific Community Rallies To Support DeVita; Immediate Suspension Of Straus’ Grant Considered

June 12, 1981

ONS Scientific Program Grows

June 20, 1980

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

Nine Saturation Program Planning Contracts Approved

May 9, 1975

Clinical Trials Issues: Maryland Law Mandates Insurance Coverage Of Patient Care Costs In Clinical Trials

July 3, 1998

Dana-Farber And Merck To Collaborate On Therapeutics.

February 15, 2008